{"altmetric_id":8415545,"counts":{"readers":{"mendeley":23,"citeulike":0,"connotea":0},"total":{"posts_count":18},"twitter":{"unique_users_count":12,"unique_users":["SCTNB","Vikas_Gupta_1","AaronGerds","BldCancerDoc","doctorpemm","Mohty_EBMT","haematologica","gmcrotty","TeamHaem","HSC_papers","mabeky","luismd1982"],"posts_count":14},"facebook":{"unique_users_count":4,"unique_users":["1043327065677305","481793341830737","469682823123363","817505918357872"],"posts_count":4}},"selected_quotes":["Fantastic review:Bone marrow #fibrosis in MF: pathogenesis, prognosistargeted strategies #mpnsm #hemepath"],"citation":{"abstract":"Bone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. Although bone marrow fibrosis is seen in a variety of malignant and non-malignant disease states, the deposition of reticulin and collagen fibrosis in the bone marrow of patients with myelofibrosis is believed to be mediated by the myelofibrosis hematopoietic stem\/progenitor cell, contributing to an impaired microenvironment favoring malignant over normal hematopoiesis. Increased expression of inflammatory cytokines, lysyl oxidase, transforming growth factor-\u03b2, impaired megakaryocyte function, and aberrant JAK-STAT signaling have all been implicated in the pathogenesis of bone marrow fibrosis. A number of studies indicate that bone marrow fibrosis is an adverse prognostic variable in myeloproliferative neoplasms. However, modern myelofibrosis prognostication systems utilized in risk-adapted treatment approaches do not include bone marrow fibrosis as a prognostic variable. The specific effect on bone marrow fibrosis of JAK2 inhibition, and other rationally based therapies currently being evaluated in myelofibrosis, has yet to be fully elucidated. Hematopoietic stem cell transplantation remains the only curative therapeutic approach that reliably results in resolution of bone marrow fibrosis in patients with myelofibrosis. Here we review the pathogenesis, biological consequences, and prognostic impact of bone marrow fibrosis. We discuss the rationale of various anti-fibrogenic treatment strategies targeting the clonal hematopoietic stem\/progenitor cell, aberrant signaling pathways, fibrogenic cytokines, and the tumor microenvironment.","altmetric_jid":"4f6fa61a3cf058f6100075cb","authors":["Abdallah Abou Zahr","Mohamed E. Salama","Nicole Carreau","Douglas Tremblay","Srdan Verstovsek","Ruben Mesa","Ronald Hoffman","John Mascarenhas","Zahr, Abdallah Abou","Salama, Mohamed E","Carreau, Nicole","Tremblay, Douglas","Verstovsek, Srdan","Mesa, Ruben","Hoffman, Ronald","Mascarenhas, John","A. A. Zahr","M. E. Salama","N. Carreau","D. Tremblay","S. Verstovsek","R. Mesa","R. Hoffman","J. Mascarenhas"],"doi":"10.3324\/haematol.2015.141283","first_seen_on":"2016-06-01T10:20:55+00:00","funders":["niehs","nci"],"issns":["1592-8721","0390-6078"],"issue":"6","journal":"Haematologica","last_mentioned_on":1474068078,"links":["http:\/\/www.haematologica.org\/content\/101\/6\/660","http:\/\/haematologica.org\/content\/101\/6\/660","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27252511?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/27252511\/?i=5&from=bone%20marrow%20fibrosis","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/27252511\/?i=1&from=mesa%20r"],"pdf_url":"http:\/\/www.haematologica.org\/content\/haematol\/101\/6\/660.full.pdf","pmid":"27252511","pubdate":"2016-06-01T00:00:00+00:00","publisher":"Haematologica","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["hematology"],"title":"Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies","type":"article","uri":"http:\/\/www.haematologica.org\/cgi\/doi\/10.3324\/haematol.2015.141283","volume":"101","mendeley_url":"http:\/\/www.mendeley.com\/research\/bone-marrow-fibrosis-myelofibrosis-pathogenesis-prognosis-targeted-strategies"},"altmetric_score":{"score":7.6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.6},"context_for_score":{"all":{"total_number_of_other_articles":8389481,"mean":7.0670107241375,"rank":1166568,"this_scored_higher_than_pct":86,"this_scored_higher_than":7220442,"rank_type":"exact","sample_size":8389481,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":273664,"mean":11.56586103346,"rank":51933,"this_scored_higher_than_pct":80,"this_scored_higher_than":221606,"rank_type":"exact","sample_size":273664,"percentile":80},"this_journal":{"total_number_of_other_articles":1200,"mean":5.3855963302752,"rank":88,"this_scored_higher_than_pct":92,"this_scored_higher_than":1110,"rank_type":"exact","sample_size":1200,"percentile":92},"similar_age_this_journal_3m":{"total_number_of_other_articles":54,"mean":2.4160377358491,"rank":4,"this_scored_higher_than_pct":92,"this_scored_higher_than":50,"rank_type":"exact","sample_size":54,"percentile":92}}},"demographics":{"poster_types":{"member_of_the_public":7,"researcher":2,"practitioner":2,"science_communicator":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":2,"Members of the public":7,"Scientists":2,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":4,"Student  > Doctoral Student":2,"Researcher":2,"Student  > Ph. D. Student":3,"Student  > Postgraduate":4,"Other":2,"Student  > Master":2,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1},"by_discipline":{"Medicine and Dentistry":14,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":5}}},"geo":{"twitter":{"CA":2,"US":3,"IT":1,"GB":1,"EC":1},"mendeley":{"SE":1,"PK":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/SCTNB\/statuses\/737941655077199872","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-01T09:39:35+00:00","author":{"name":"Dr T. Comeau , MD","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000365246082\/373bc9bced36e8f90f0d52d727fc6b34_normal.jpeg","description":"Director New Brunswick Stem Cell Transplant Program ; SCT Physician ; #hematology: #leukemia, #MDS, #lymphoma, #mmsm , #apheresis, #bmtsm , #immunotherapy","id_on_source":"SCTNB","tweeter_id":"314498013","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":1150},"tweet_id":"737941655077199872"},{"url":"http:\/\/twitter.com\/Vikas_Gupta_1\/statuses\/737975024993308672","license":"gnip","rt":["AaronGerds"],"citation_ids":[8415545],"posted_on":"2016-06-01T11:52:11+00:00","author":{"name":"Vikas Gupta","url":"http:\/\/mpncanada.com","image":"https:\/\/pbs.twimg.com\/profile_images\/502281299634442240\/1D6uKjQH_normal.jpeg","description":"Director, The Elizabeth and Tony Comper MPN Program, Princess Margaret Cancer Center; Founder and President, Canadian MPN Group; tweets are personal","id_on_source":"Vikas_Gupta_1","tweeter_id":"2597316224","geo":{"lt":43.70011,"ln":-79.4163,"country":"CA"},"followers":583},"tweet_id":"737975024993308672"},{"url":"http:\/\/twitter.com\/AaronGerds\/statuses\/737971880523616258","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-01T11:39:41+00:00","author":{"name":"Aaron Gerds MD","url":"http:\/\/my.clevelandclinic.org\/staff_directory\/staff_display.aspx?doctorid=17946","image":"https:\/\/pbs.twimg.com\/profile_images\/542347942602874880\/eWSSHQJe_normal.jpeg","description":"Assistant Professor | Cleveland Clinic Taussig Cancer Institute | Opinions here are mine","id_on_source":"AaronGerds","tweeter_id":"2912826923","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":1053},"tweet_id":"737971880523616258"},{"url":"http:\/\/twitter.com\/BldCancerDoc\/statuses\/737990690446135296","license":"gnip","rt":["AaronGerds"],"citation_ids":[8415545],"posted_on":"2016-06-01T12:54:26+00:00","author":{"name":"Navneet Majhail, MD","url":"http:\/\/clevelandclinic.org\/bmt","image":"https:\/\/pbs.twimg.com\/profile_images\/518962445641986048\/xWAmho1l_normal.jpeg","description":"Director, Blood & Marrow Transplant Program, @ClevelandClinic | Vice President @ASBMT | Blood cancers, BMT, health policy, musings as doc | Opinions my own","id_on_source":"BldCancerDoc","tweeter_id":"2809497047","geo":{"lt":41.4995,"ln":-81.69541,"country":"US"},"followers":4771},"tweet_id":"737990690446135296"},{"url":"http:\/\/twitter.com\/doctorpemm\/statuses\/738188713482686464","license":"gnip","rt":["AaronGerds"],"citation_ids":[8415545],"posted_on":"2016-06-02T02:01:18+00:00","author":{"name":"Naveen Pemmaraju, MD","url":"http:\/\/faculty.mdanderson.org\/Naveen_Pemmaraju\/Default.asp?SNID=0","image":"https:\/\/pbs.twimg.com\/profile_images\/452585744775667713\/6LbD0gid_normal.jpeg","description":"Hematologist\/Oncologist Research: #mpnsm; #BPDCN; #BMFSM #Leusm;COI: https:\/\/ash.confex.com\/ash\/2016\/webprogram\/Session8731.html Tweets:my own thoughts&opinions","id_on_source":"doctorpemm","tweeter_id":"2429552622","geo":{"lt":null,"ln":null},"followers":3381},"tweet_id":"738188713482686464"},{"url":"http:\/\/twitter.com\/Mohty_EBMT\/statuses\/738251893038850049","license":"gnip","rt":["AaronGerds"],"citation_ids":[8415545],"posted_on":"2016-06-02T06:12:22+00:00","author":{"name":"Mohamad Mohty","url":"http:\/\/www.ebmt.org","image":"https:\/\/pbs.twimg.com\/profile_images\/480924346299346944\/OOXDgK3a_normal.jpeg","description":"Professor of Hematology and president of the European society for Blood and Marrrow Transplantation (EBMT)","id_on_source":"Mohty_EBMT","tweeter_id":"2626263112","geo":{"lt":null,"ln":null},"followers":2756},"tweet_id":"738251893038850049"},{"url":"http:\/\/twitter.com\/haematologica\/statuses\/738617798801248256","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-03T06:26:20+00:00","author":{"name":"Haematologica","url":"http:\/\/www.haematologica.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2694311828\/3b3efe7ee65409ca11124d3fb2429e5d_normal.jpeg","description":"Haematologica: the journal of the European Hematology Association (EHA), open access journal","id_on_source":"haematologica","tweeter_id":"583528006","geo":{"lt":45.18446,"ln":9.16145,"country":"IT"},"followers":1915},"tweet_id":"738617798801248256"},{"url":"http:\/\/twitter.com\/gmcrotty\/statuses\/738630475913142273","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-03T07:16:43+00:00","author":{"name":"Gerard Crotty","url":"http:\/\/about.me\/gerard_crotty","image":"https:\/\/pbs.twimg.com\/profile_images\/1995144909\/image_normal.jpg","description":"Blood doctor (consultant haematologist). Past President of Irish Hospital Consultants Association. Personal views. Retweets are not endorsements. #QI #IHCA","id_on_source":"gmcrotty","tweeter_id":"58644094","geo":{"lt":null,"ln":null},"followers":11892},"tweet_id":"738630475913142273"},{"url":"http:\/\/twitter.com\/TeamHaem\/statuses\/738632169720012800","license":"gnip","rt":["gmcrotty"],"citation_ids":[8415545],"posted_on":"2016-06-03T07:23:27+00:00","author":{"name":"TeamHaem","url":"http:\/\/teamhaem.com","image":"https:\/\/pbs.twimg.com\/profile_images\/741020408716132352\/IZ3LYVMh_normal.jpg","description":"Haematology Education: debate, share wisdom, get involved. #FOAMed: E Graves, A McGregor, J Young, R Evans, L Dunning, N Redding, C Shrubsole","id_on_source":"TeamHaem","tweeter_id":"932823252","geo":{"lt":54.97328,"ln":-1.61396,"country":"GB"},"followers":3404},"tweet_id":"738632169720012800"},{"url":"http:\/\/twitter.com\/HSC_papers\/statuses\/738692238578851840","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-03T11:22:08+00:00","author":{"name":"Hematopoiesis","image":"https:\/\/pbs.twimg.com\/profile_images\/618441198634561537\/Y2u99HYj_normal.jpg","id_on_source":"HSC_papers","tweeter_id":"3271095818","geo":{"lt":null,"ln":null},"followers":85},"tweet_id":"738692238578851840"},{"url":"http:\/\/twitter.com\/doctorpemm\/statuses\/739572528184713217","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-05T21:40:05+00:00","author":{"name":"Naveen Pemmaraju, MD","url":"http:\/\/faculty.mdanderson.org\/Naveen_Pemmaraju\/Default.asp?SNID=0","image":"https:\/\/pbs.twimg.com\/profile_images\/452585744775667713\/6LbD0gid_normal.jpeg","description":"Hematologist\/Oncologist Research: #mpnsm; #BPDCN; #BMFSM #Leusm;COI: https:\/\/ash.confex.com\/ash\/2016\/webprogram\/Session8731.html Tweets:my own thoughts&opinions","id_on_source":"doctorpemm","tweeter_id":"2429552622","geo":{"lt":null,"ln":null},"followers":3381},"tweet_id":"739572528184713217"},{"url":"http:\/\/twitter.com\/doctorpemm\/statuses\/743951250220146689","license":"gnip","citation_ids":[8415545],"posted_on":"2016-06-17T23:39:34+00:00","author":{"name":"Naveen Pemmaraju, MD","url":"http:\/\/faculty.mdanderson.org\/Naveen_Pemmaraju\/Default.asp?SNID=0","image":"https:\/\/pbs.twimg.com\/profile_images\/452585744775667713\/6LbD0gid_normal.jpeg","description":"Hematologist\/Oncologist Research: #mpnsm; #BPDCN; #BMFSM #Leusm;COI: https:\/\/ash.confex.com\/ash\/2016\/webprogram\/Session8731.html Tweets:my own thoughts&opinions","id_on_source":"doctorpemm","tweeter_id":"2429552622","geo":{"lt":null,"ln":null},"followers":3381},"tweet_id":"743951250220146689"},{"url":"http:\/\/twitter.com\/mabeky\/statuses\/744935204351938561","license":"gnip","rt":["doctorpemm"],"citation_ids":[8415545],"posted_on":"2016-06-20T16:49:27+00:00","author":{"name":"Mary Silverstein","image":"https:\/\/pbs.twimg.com\/profile_images\/645243613220175872\/sIh6Qif0_normal.jpg","description":"Leukemia Department Administrator at MD Anderson Cancer Center","id_on_source":"mabeky","tweeter_id":"221014506","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":82},"tweet_id":"744935204351938561"},{"url":"http:\/\/twitter.com\/luismd1982\/statuses\/776923948588072960","license":"gnip","rt":["haematologica"],"citation_ids":[8415545],"posted_on":"2016-09-16T23:21:18+00:00","author":{"name":"Luis Alvarado Su\u00e1rez","image":"https:\/\/pbs.twimg.com\/profile_images\/1287015140\/Imagen_023_normal.jpg","description":"M\u00e9dico desde 1982,trabajando por la Salud de la poblaci\u00f3n e interesado por el acontecer nacional y mundial.","id_on_source":"luismd1982","tweeter_id":"271766631","geo":{"lt":-2.20584,"ln":-79.90795,"country":"EC"},"followers":548},"tweet_id":"776923948588072960"}],"facebook":[{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1232539880089355&id=1043327065677305","license":"public","citation_ids":[8415545],"posted_on":"2016-06-01T09:18:58+00:00","summary":"Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies\n\nBone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. Although bone marrow fibrosis is seen","author":{"name":"Blood and Hematology","url":"https:\/\/www.facebook.com\/1043327065677305","facebook_wall_name":"Blood and Hematology","image":"https:\/\/graph.facebook.com\/1043327065677305\/picture","id_on_source":"1043327065677305"}},{"title":"Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1232279323448798&id=481793341830737","license":"public","citation_ids":[8415545],"posted_on":"2016-06-03T06:26:16+00:00","summary":"Bone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. Although bone marrow fibrosis is seen in a variety of malignant and non-malignant disease states, the deposition of reticulin","author":{"name":"Haematologica","url":"https:\/\/www.facebook.com\/481793341830737","facebook_wall_name":"Haematologica","image":"https:\/\/graph.facebook.com\/481793341830737\/picture","id_on_source":"481793341830737"}},{"title":"Haematologica","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1016445855113721&id=469682823123363","license":"public","citation_ids":[8415545],"posted_on":"2016-06-05T11:46:07+00:00","summary":"Bone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. Although bone marrow fibrosis is seen in a variety of malignant and non-malignant disease states, the deposition of reticulin","author":{"name":"\u041e\u0442\u0434\u0435\u043b\u0435\u043d\u0438\u0435 \u0442\u0440\u0430\u043d\u0441\u043f\u043b\u0430\u043d\u0442\u0430\u0446\u0438\u0438 \u043a\u043e\u0441\u0442\u043d\u043e\u0433\u043e \u043c\u043e\u0437\u0433\u0430","url":"https:\/\/www.facebook.com\/469682823123363","facebook_wall_name":"\u041e\u0442\u0434\u0435\u043b\u0435\u043d\u0438\u0435 \u0442\u0440\u0430\u043d\u0441\u043f\u043b\u0430\u043d\u0442\u0430\u0446\u0438\u0438 \u043a\u043e\u0441\u0442\u043d\u043e\u0433\u043e \u043c\u043e\u0437\u0433\u0430","image":"https:\/\/graph.facebook.com\/469682823123363\/picture","id_on_source":"469682823123363"}},{"title":"Haematologica","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=915533651888431&id=817505918357872","license":"public","citation_ids":[8415545],"posted_on":"2016-06-04T02:01:33+00:00","summary":"Bone marrow fibrosis is a central pathological feature and World Health Organization major diagnostic criterion of myelofibrosis. Although bone marrow fibrosis is seen in a variety of malignant and non-malignant disease states, the deposition of reticulin","author":{"name":"\u0426\u0435\u043d\u0442\u0440 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438","url":"https:\/\/www.facebook.com\/817505918357872","facebook_wall_name":"\u0426\u0435\u043d\u0442\u0440 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438","image":"https:\/\/graph.facebook.com\/817505918357872\/picture","id_on_source":"817505918357872"}}]}}